Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor.
Sun L, Xi S, Zhou Z, Zhang F, Hu P, Cui Y, Wu S, Wang Y, Wu S, Wang Y, Du Y, Zheng J, Yang H, Chen M, Yan Q, Yu D, Shi C, Zhang Y, Xie D, Guan XY, Li Y.
Sun L, et al. Among authors: wang y.
Oncogene. 2022 Jan;41(5):732-744. doi: 10.1038/s41388-021-02130-8. Epub 2021 Nov 29.
Oncogene. 2022.
PMID: 34845378